SCHEMBL16907284

SCHEMBL16907284

C1=C(SSc2cnn[nH]2)NNN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7202635 0.78 — —
SCHEMBL9868986 0.64 — —
SCHEMBL4146105 0.61 — —
SCHEMBL11426676 0.56 — —
SCHEMBL6051450 0.56 — —
SCHEMBL12221453 0.56 — —
SCHEMBL6051456 0.56 — —
SCHEMBL4311579 0.55 CYP2C9 (0.33) —
SCHEMBL14220785 0.54 — —
SCHEMBL4318926 0.53 MAPK1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3094619-B1 HETEROARYL DISULFIDE COMPOUNDS AS ALLOSTERIC EFFECTORS FOR INCREASING THE OXYGEN-BINDING AFFINITY OF HEMOGLOBIN MASSACHUSETTS GEN HOSPITAL (US) 2019-07-31 — — EP disclosed
WO-2015106240-A1 HETEROARYL DISULFIDE COMPOUNDS AS ALLOSTERIC EFFECTORS FOR INCREASING THE OXYGEN-BINDING AFFINITY OF HEMOGLOBIN THE GENERAL HOSPITAL CORPORATION (US) 2015-07-16 — — WO disclosed
Send feedback